CD4 and neoplasm: We sorted CD4+ CD25+ (Treg) and CD4+ CD25− (conventional T) T cell subsets from the spleen from PBS- or BLM-treated tumor-bearing mice, and tested their capacity to blunt IFNγ production by OT-I cells in an in vitro assay.